Matthias Karrasch

Phase Ib Trial of Mutant Herpes Simplex Virus G207 Inoculated Pre-and Post-tumor Resection for Recurrent GBM

James M. Markert, Peter Liechty, Wenquan Wang et al. · Molecular Therapy · 2008 · 398 citations · Full text

A Phase 1 Trial of Oncolytic HSV-1, G207, Given in Combination With Radiation for Recurrent GBM Demonstrates Safety and Radiographic Responses

James M. Markert, Shantanu N. Razdan, Hui‐Chien Kuo et al. · Molecular Therapy · 2014 · 305 citations · Full text

A double-blind randomized multicentre clinical trial to evaluate the efficacy and safety of two doses of etomoxir in comparison with placebo in patients with moderate congestive heart failure: the ERGO (etomoxir for the recovery of glucose oxidation) study

Christian Holubarsch, M. Rohrbach, Matthias Karrasch et al. · Clinical Science · 2007 · 280 citations · Full text

Heart Failure, Etomoxir Groups, Metabolic Disorder +18

Phase I, Open-Label, Dose-Escalating Study of a Genetically Engineered Herpes Simplex Virus, NV1020, in Subjects with Metastatic Colorectal Carcinoma to the Liver

Nancy E. Kemeny, Karen T. Brown, Anne M. Covey et al. · Human Gene Therapy · 2006 · 169 citations

Vaccination trial with HPV16 L1E7 chimeric virus‐like particles in women suffering from high grade cervical intraepithelial neoplasia (CIN 2/3)

Andreas M. Kaufmann, John D. Nieland, Ingrid Jochmus et al. · International Journal of Cancer · 2007 · 134 citations